Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
136 USD | +3.84% | +4.12% | +18.91% |
May. 02 | Baird Adjusts Xylem Price Target to $155 From $151 | MT |
May. 02 | Melius Research Raises Xylem's Price Target to $128 From $127 | MT |
Financials (USD)
Sales 2024 * | 8.54B | Sales 2025 * | 8.99B | Capitalization | 32.88B |
---|---|---|---|---|---|
Net income 2024 * | 841M | Net income 2025 * | 989M | EV / Sales 2024 * | 3.93 x |
Net Debt 2024 * | 695M | Net Debt 2025 * | 134M | EV / Sales 2025 * | 3.67 x |
P/E ratio 2024 * |
39.4
x | P/E ratio 2025 * |
34
x | Employees | 23,000 |
Yield 2024 * |
1.06% | Yield 2025 * |
1.13% | Free-Float | 93.17% |
Latest transcript on Xylem Inc.
1 day | +3.84% | ||
1 week | +4.12% | ||
Current month | +4.05% | ||
1 month | +6.14% | ||
3 months | +17.82% | ||
6 months | +44.19% | ||
Current year | +18.91% |
Managers | Title | Age | Since |
---|---|---|---|
Matthew Pine
CEO | Chief Executive Officer | 52 | 20-02-29 |
William Grogan
DFI | Director of Finance/CFO | 45 | 23-09-30 |
David Flinton
CTO | Chief Tech/Sci/R&D Officer | 53 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Loranger
BRD | Director/Board Member | 72 | 11-10-30 |
Lisa Glatch
BRD | Director/Board Member | 61 | 23-05-23 |
Robert Friel
CHM | Chairman | 68 | 12-12-11 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.28% | 10 M€ | +6.14% | - | |
0.97% | 1 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-02 | 136 | +3.84% | 2,784,916 |
24-05-01 | 131 | +0.20% | 1,773,974 |
24-04-30 | 130.7 | -1.43% | 1,397,841 |
24-04-29 | 132.6 | +0.14% | 1,277,846 |
24-04-26 | 132.4 | +1.37% | 1,112,276 |
Delayed Quote Nyse, May 02, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.91% | 32.88B | |
+11.26% | 82.32B | |
+15.19% | 68.15B | |
+20.05% | 37.47B | |
+12.78% | 28.75B | |
+3.35% | 26.79B | |
+13.16% | 24.83B | |
+0.37% | 25.18B | |
+15.43% | 24.4B | |
+16.26% | 17.78B |
- Stock Market
- Equities
- XYL Stock